Literature DB >> 25284032

Lennox-Gastaut syndrome: a consensus approach to differential diagnosis.

Blaise F D Bourgeois1, Laurie M Douglass, Raman Sankar.   

Abstract

Lennox-Gastaut syndrome (LGS) is a severe epileptic encephalopathy that shares many features and characteristics of other treatment-resistant childhood epilepsies. Accurate and early diagnosis is essential to both prognosis and overall patient management. However, accurate diagnosis of LGS can be clinically challenging. This article summarizes key characteristics of LGS and areas of overlap with other childhood epilepsies. Drawing upon input from a committee of established LGS experts convened in June 2012 in Chicago, Illinois, the authors highlight key diagnostic tests for making the differential diagnosis and propose a diagnostic scheme for people with suspected LGS. Wiley Periodicals, Inc.
© 2014 International League Against Epilepsy.

Entities:  

Keywords:  Encephalopathy; Epilepsy; Infantile spasms; Seizure; West syndrome

Mesh:

Year:  2014        PMID: 25284032     DOI: 10.1111/epi.12567

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  17 in total

1.  Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.

Authors:  Victoria Golub; D Samba Reddy
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Understanding Lennox-Gastaut syndrome: insights from focal epilepsy patients with Lennox-Gastaut features.

Authors:  Sophie Dupont; Raluca Banica-Wolters; Isabelle An-Gourfinkel; Virginie Lambrecq; Vincent Navarro; Claude Adam; Vi-Huong Nguyen-Michel
Journal:  J Neurol       Date:  2017-06-05       Impact factor: 4.849

3.  Case Report: Late-Onset Lennox-Gastaut Syndrome Treated With Stereotactic Electroencephalography-Guided Radiofrequency Thermocoagulation Before Craniotomy.

Authors:  Sixian Li; Xiaodong Cai; Chen Yao; Yuanqing Wang; Xiaohua Xiao; Huafeng Yang; Yi Yao; Lei Chen
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

4.  Dynamics of sensorimotor cortex activation during absence and myoclonic seizures in a mouse model of juvenile myoclonic epilepsy.

Authors:  Li Ding; Martin J Gallagher
Journal:  Epilepsia       Date:  2016-08-30       Impact factor: 5.864

5.  Evolution and course of early life developmental encephalopathic epilepsies: Focus on Lennox-Gastaut syndrome.

Authors:  Anne T Berg; Susan R Levy; Francine M Testa
Journal:  Epilepsia       Date:  2018-09-26       Impact factor: 5.864

Review 6.  Modeling epileptic spasms during infancy: Are we heading for the treatment yet?

Authors:  Libor Velíšek; Jana Velíšková
Journal:  Pharmacol Ther       Date:  2020-05-15       Impact factor: 12.310

Review 7.  Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox-Gastaut syndrome.

Authors:  Michele A Faulkner
Journal:  Ther Clin Risk Manag       Date:  2015-06-08       Impact factor: 2.423

8.  Brainstem dysfunction in patients with late-onset Lennox-Gastaut syndrome: Voxel-based morphometry and tract-based spatial statistics study.

Authors:  Kang Min Park; Yun Jung Hur; Sung Eun Kim
Journal:  Ann Indian Acad Neurol       Date:  2016 Oct-Dec       Impact factor: 1.383

Review 9.  Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions.

Authors:  Adam P Ostendorf; Yu-Tze Ng
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-20       Impact factor: 2.570

10.  Transcranial Direct Current Stimulation for Treatment of Childhood Pharmacoresistant Lennox-Gastaut Syndrome: A Pilot Study.

Authors:  Narong Auvichayapat; Katenipa Sinsupan; Orathai Tunkamnerdthai; Paradee Auvichayapat
Journal:  Front Neurol       Date:  2016-05-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.